Journal of Pediatric Health Care
Volume 23, Issue 1 , Pages 49-53 , January 2009

Ecstasy in the Emergency Department: MDMA Ingestion

  • Karin Reuter-Rice, PhD, RN, CPNP

      Affiliations

    • Corresponding Author InformationCorrespondence: Karin Reuter-Rice, PhD, RN, CPNP, Rady Children's Hospital, Division of Pediatric Critical Care, MC 5065, 3020 Children's Way, San Diego, CA 92123;

References 

  1. Boyer E, Shannon M. The serotonin syndrome. New England Journal of Medicine. 2005;352:1112–1120
  2. Britt GC, McCance-Katz E. A brief overview of the clinical pharmacology of “Club Drugs.”. Substance Use & Misuse. 2005;40:1189–1201
  3. Gillman P. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia. 2005;95:434–441
  4. Henry J. Metabolic consequences of drug misuse. British Journal of Anaesthesia. 2000;85:136–142
  5. Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Canadian Medical Association Journal. 2001;165:917–928
  6. Klein M, Kramer F. Rave drugs: Pharmacological considerations. AANA Journal. 2004;72:61–67
  7. Liechti M, Kunz I, Kupferschmidt H. Acute medical problems due to Ecstasy use. Swiss Medical Weekly. 2005;135:652–657Retrieved August 29, 2008, from www.smw.ch/dfe/set_archiv.asp
  8. Office of National Drug Control Policy . National drug control strategy; 2008 annual report. 2008;Retrieved August 29, 2008, from www.whitehousedrugpolicy.gov/publications/policy/ndcs08/2008ndcs.pdf
  9. Oesterheld J, Armstrong S, Cozza K. Ecstasy: Pharmacodynamic and pharmacokinetic interactions. Psychosomatics. 2004;45:84–87
  10. U.S. Department of Health and Human Services. (2008). MDMA (Ecstasy). National Institute on Drug Abuse. Retrieved August 29, 2008, from www.nida.nih.gov/PDF/Infofacts/MDMA08.pdf.
  11. U.S. Department of Health and Human Services. (2006). Research report series: MDMA (Ecstasy) abuse. National Institute on Drug Abuse. Retrieved August 29, 2008, from www.drugabuse.gov/PDF/RRmdma.pdf.
  12. Weir E. Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal. 2000;162:1843–1848Retrieved September 4, 2008, from http://www.cmaj.ca/cgi/reprint/162/13/1843
  13. Zagnoni P, Albano C. Psychostimulants and epilepsy. Epilepsia. 2002;43:28–31Retrieved September 4, 2008, from www.3.interscience.wiley.com/cgi-bin/fulltext/118940645/PDFSTART

PII: S0891-5245(08)00274-5

doi: 10.1016/j.pedhc.2008.09.002

Journal of Pediatric Health Care
Volume 23, Issue 1 , Pages 49-53 , January 2009

Article Tools